High-dose therapy and autologous stem cell transplantation (ASCT) for systemic AL amyloidosis (AL): A report on 16 cases.

被引：0
|
作者：
Moreau, P [1 ]
Facon, T [1 ]
Leblond, V [1 ]
Attal, M [1 ]
Caillot, D [1 ]
Nedellec, G [1 ]
Huynh, A [1 ]
Bataille, R [1 ]
Harousseau, JL [1 ]
机构：
[1] DEPT HEMATOL,NANTES,FRANCE
来源：
EXPERIMENTAL HEMATOLOGY | 1997年 / 25卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [1] High-dose therapy and autologous stem cell transplantation (ASCT) for systemic amyloidosis (AL): Report of 9 cases.
    Amoura, Z
    Leblond, V
    Azar, N
    Montalescot, G
    Bagnis, C
    Schmidt, J
    de Gennes, C
    Wechsler, B
    Boccaccio, C
    Godeau, P
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S234 - S234
  • [2] Prognostic factors for survival and response after high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) for systemic amyloidosis (AL): A report on 22 cases.
    Moreau, P
    Leblond, V
    Bourquelot, P
    Facon, T
    Attal, M
    Caillot, D
    Audhuy, B
    Nedellec, G
    Huynh, A
    Ferrant, A
    Bataille, R
    Harousseau, JL
    BLOOD, 1997, 90 (10) : 490 - 490
  • [3] Prognostic factors for survival and response after high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) for systemic amyloidosis (AL): A report on 22 cases.
    Moreau, P
    Leblond, V
    Bourquelot, P
    Facon, T
    Attal, M
    Caillot, D
    Audhuy, B
    Nedellec, G
    Huynh, A
    Ferrant, A
    Bataille, R
    Harousseau, JL
    BONE MARROW TRANSPLANTATION, 1998, 21 : S204 - S204
  • [4] Prognostic factors for surival and response after high-dose therapy and autologous stem cell transplantation (ASCT) in systemic AL amyloidosis: a report on 21 patients
    Moreau, P
    Leblond, V
    Bourquelot, P
    Facon, T
    Huynh, A
    Caillot, D
    Hermine, O
    Attal, M
    Hamidou, M
    Nedellec, G
    Ferrant, A
    Audhuy, B
    Bataille, R
    Milpied, N
    Harousseau, JL
    AMYLOID AND AMYLOIDOSIS 1998, 1999, : 105 - 107
  • [5] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
  • [6] High-dose melphalan followed by autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis
    Knop, S
    Lengerke, C
    Hebart, H
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S165 - S165
  • [7] HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION IN AMYLOIDOSIS-AL
    MAJOLINO, I
    MARCENO, R
    PECORARO, G
    SCIME, R
    VASTA, S
    LIBERTI, G
    RIZZO, A
    INDOVINA, A
    CARONIA, F
    HAEMATOLOGICA, 1993, 78 (01) : 68 - 71
  • [8] Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation
    Dimopoulos, Meletios A.
    LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 963 - 964
  • [9] Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients
    Moreau, P
    Leblond, V
    Bourquelot, P
    Facon, T
    Huynh, A
    Caillot, D
    Hermine, O
    Attal, M
    Hamidou, M
    Nedellec, G
    Ferrant, A
    Audhuy, B
    Bataille, R
    Milpied, N
    Harousseau, JL
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (04) : 766 - 769
  • [10] High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    ACTA HAEMATOLOGICA, 2020, 143 (04) : 381 - 387
12345